Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-19

Clinical Trial Update: Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sofosbuvir-containing regimens for chronic hepatitis C virus infection genotype 3 has completed enrollment and status is reported as co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Humanity and Health Research Centre | Conditions: Chronic Hepatitis C Infection | Phase 3 | Status: COMPLETED